Report Highlights
-
The global market for marine biotechnology products and processes is estimated at $2.4 billion in 2002, a 9.4% increase from 2001.
-
The non-U.S. market for marine biotechnology applications in 2002 is estimated at more than $1.6 billion, or roughly twice the size of the U.S. market.
-
The non-U.S. market is projected to rise over the next five years at an average annual growth rate (AAGR) of 6.4%.
-
This is faster than the U.S. market with an AAGR of 4.7% and will exceed $2.2 billion in 2007.
-
The U.S. marine biotechnology market is projected to surpass $1 billion by 2007.
INTRODUCTION
Marine biotechnology is a relatively new field that involves the discovery and application of products and processes derived from marine organisms. Its promising future reflects the tremendous biodiversity of the world's oceans and seas that cover more than three-quarters of the earth's surface.
Most major groups of living organisms primarily or exclusively are marine, and the demands of their environment have led these organisms to evolve unique structures, metabolic pathways, reproductive systems and sensory and defense mechanisms. Many of these same properties have important potential applications in the terrestrial world. For example, research into the ways that marine organisms adhere to wet surfaces, or prevent other organisms from adhering to them, is yielding useful new technologies. These include both adhesion inhibitors (e.g., antifouling coatings for ship hulls) and new types of adhesives such as medical "glues" for joining tissue or promoting cell attachment in tissue engineering applications.
Since BCC first approached the subject 10 years ago, to our knowledge there has been no broad-based quantitative analysis that focused specifically on the marine biotechnology industry. This unique study provides the reader with an understanding of the commercial potential associated with the biodiversity that exists in the marine environment. It is coupled with an overall, quantitative view of the emerging U.S. marine biotechnology industry and potential domestic and international markets for U.S. marine biotechnology-related products and services.
This analysis is tailored especially for decision makers in biotechnology marketing, strategic planning, development, management and public policy.
SCOPE OF STUDY
This report describes the U.S. marine biotechnology industry and the emerging market for marine biotechnology products and services. Specific topics covered include:
- Major types and applications of marine biotechnology
- Industry structure
- Market size and segmentation, including historical data on sales by product/service and enduser segment
- Market drivers
- Detailed market projections through 2007
- User requirements and success factors
- Competition and market shares
- Observations and conclusions regarding the future of the marine biotechnology industry.
AUTHOR'S CREDENTIALS
The author of this study, Andrew McWilliams, is a partner in the Boston-based international technology and software consulting firm of 43rd Parallel LLC. He has over 25 years experience in market forecasting and strategy consulting, particularly in technology-intensive industries such as software and e-business.
Related Reports
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More